These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 29861352)

  • 1. Impact of timing of radiation therapy on outcomes in atypical meningioma: A clinical audit.
    Pant S; Tonse R; Kannan S; Moiyadi A; Shetty P; Epari S; Sahay A; Sastri GJ; Jalali R; Gupta T
    Pract Radiat Oncol; 2018; 8(5):e275-e284. PubMed ID: 29861352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revisiting Adjuvant Radiotherapy After Gross Total Resection of World Health Organization Grade II Meningioma.
    Graffeo CS; Leeper HE; Perry A; Uhm JH; Lachance DJ; Brown PD; Ma DJ; Van Gompel JJ; Giannini C; Johnson DR; Raghunathan A
    World Neurosurg; 2017 Jul; 103():655-663. PubMed ID: 28450233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histopathological features predictive of local control of atypical meningioma after surgery and adjuvant radiotherapy.
    Chen WC; Magill ST; Wu A; Vasudevan HN; Morin O; Aghi MK; Theodosopoulos PV; Perry A; McDermott MW; Sneed PK; Braunstein SE; Raleigh DR
    J Neurosurg; 2018 Apr; 130(2):443-450. PubMed ID: 29624151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salvage therapy outcomes for atypical meningioma.
    Chen WC; Hara J; Magill ST; Wu A; Aghi MK; Theodosopoulos PV; Perry A; McDermott MW; Sneed PK; Raleigh DR; Braunstein SE
    J Neurooncol; 2018 Jun; 138(2):425-433. PubMed ID: 29480505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant radiation therapy, local recurrence, and the need for salvage therapy in atypical meningioma.
    Aizer AA; Arvold ND; Catalano P; Claus EB; Golby AJ; Johnson MD; Al-Mefty O; Wen PY; Reardon DA; Lee EQ; Nayak L; Rinne ML; Beroukhim R; Weiss SE; Ramkissoon SH; Abedalthagafi M; Santagata S; Dunn IF; Alexander BM
    Neuro Oncol; 2014 Nov; 16(11):1547-53. PubMed ID: 24891451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. World Health Organization Grade II Meningiomas: The Role of Adjuvant/Salvage Gamma Knife Surgery After Initial Surgery and Prognostic Factor Assessment.
    Liu X; Shan B; Wang M; Xu J
    World Neurosurg; 2018 Jan; 109():e352-e362. PubMed ID: 28987849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term experience with World Health Organization grade III (malignant) meningiomas at a single institution.
    Rosenberg LA; Prayson RA; Lee J; Reddy C; Chao ST; Barnett GH; Vogelbaum MA; Suh JH
    Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):427-32. PubMed ID: 19427553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation Therapy for Residual or Recurrent Atypical Meningioma: The Effects of Modality, Timing, and Tumor Pathology on Long-Term Outcomes.
    Sun SQ; Cai C; Murphy RK; DeWees T; Dacey RG; Grubb RL; Rich KM; Zipfel GJ; Dowling JL; Leuthardt EC; Simpson JR; Robinson CG; Chicoine MR; Perrin RJ; Huang J; Kim AH
    Neurosurgery; 2016 Jul; 79(1):23-32. PubMed ID: 26645969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of atypical and malignant meningiomas: role of high-dose, 3D-conformal radiation therapy.
    Hug EB; Devries A; Thornton AF; Munzenride JE; Pardo FS; Hedley-Whyte ET; Bussiere MR; Ojemann R
    J Neurooncol; 2000 Jun; 48(2):151-60. PubMed ID: 11083080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of adjuvant radiotherapy for atypical and anaplastic meningioma.
    Zhu H; Bi WL; Aizer A; Hua L; Tian M; Den J; Tang H; Chen H; Wang Y; Mao Y; Dunn IF; Xie Q; Gong Y
    Cancer Med; 2019 Jan; 8(1):13-20. PubMed ID: 30680963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clear Cell Meningioma: A Clinicopathologic Study of a Rare Meningioma Subtype in 35 Patients.
    Soni P; Li S; Sagar S; Prayson RA; Angelov L; Mohammadi AM; Barnett GH; Recinos PF; Kshettry VR
    World Neurosurg; 2020 Sep; 141():e334-e340. PubMed ID: 32445901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determining the role of adjuvant radiotherapy in the management of meningioma: a Surveillance, Epidemiology, and End Results analysis.
    Reddy AK; Ryoo JS; Denyer S; McGuire LS; Mehta AI
    Neurosurg Focus; 2019 Jun; 46(6):E3. PubMed ID: 31153148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Term Clinical Outcomes of Pencil Beam Scanning Proton Therapy for Benign and Non-benign Intracranial Meningiomas.
    Murray FR; Snider JW; Bolsi A; Lomax AJ; Walser M; Kliebsch U; Schneider RA; Weber DC
    Int J Radiat Oncol Biol Phys; 2017 Dec; 99(5):1190-1198. PubMed ID: 28939227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progression-Free Survival and Factors Associated with Postoperative Recurrence in 126 Patients with Atypical Intracranial Meningioma.
    Phonwijit L; Khawprapa C; Sitthinamsuwan B
    World Neurosurg; 2017 Nov; 107():698-705. PubMed ID: 28838877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gross Tumor and Intracranial Control Benefits with Fractionated Radiotherapy Compared with Stereotactic Radiosurgery for Patients with WHO Grade 2 Meningioma.
    Gravbrot N; Rock CB; Weil CR; Rock CB; Burt LM; DeCesaris CM; Jensen RL; Shrieve DC; Cannon DM
    World Neurosurg; 2024 Aug; 188():e259-e266. PubMed ID: 38777319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of Treatment Response and Survival Outcomes in Meningioma Recurrence with Atypical or Anaplastic Histology.
    Chohan MO; Ryan CT; Singh R; Lanning RM; Reiner AS; Rosenblum MK; Tabar V; Gutin PH
    Neurosurgery; 2018 Jun; 82(6):824-832. PubMed ID: 28645194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical Meningiomas: Histologic and Clinical Factors Associated With Recurrence.
    Ros-Sanjuan A; Iglesias-Moroño S; Carrasco-Brenes A; Bautista-Ojeda D; Arraez-Sanchez MA
    World Neurosurg; 2019 May; 125():e248-e256. PubMed ID: 30684705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early or late radiotherapy following gross or subtotal resection for atypical meningiomas: Clinical outcomes and local control.
    Dohm A; McTyre ER; Chan MD; Fan C; Isom S; Bourland JD; Mott RT; Cramer CK; Tatter SB; Laxton AW
    J Clin Neurosci; 2017 Dec; 46():90-98. PubMed ID: 28917587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term recurrence rates of atypical meningiomas after gross total resection with or without postoperative adjuvant radiation.
    Aghi MK; Carter BS; Cosgrove GR; Ojemann RG; Amin-Hanjani S; Martuza RL; Curry WT; Barker FG
    Neurosurgery; 2009 Jan; 64(1):56-60; discussion 60. PubMed ID: 19145156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant radiation for WHO grade II and III intracranial meningiomas: insights on survival and practice patterns from a National Cancer Registry.
    Brown DA; Goyal A; Kerezoudis P; Alvi MA; Himes BT; Bydon M; Van Gompel JJ; Chaichana KL; Quiñones-Hinojosa A; Burns TC; Yan E; Parney IF
    J Neurooncol; 2020 Sep; 149(2):293-303. PubMed ID: 32860156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.